Correlates of the rate of decline of cd4+ lymphocytes among injection drug users infected with the human immunodeficiency virus

Philip Alcabes, Ellie Schoenbaum, Robert S. Klein

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Changes in the level of CD4-bearing T-lymphocytes in injection drug users infected with the human immunodeficiency virus were evaluated in a sample of 318 subjects enrolled from a methadone program in the Bronx, New York, from 1985 through 1989. Follow-up continued through 1990. The percentage of CD4+ T-lymphocytes (CD4%) was used to maximize the stability of measurements. The rate of decline of the CD4% was determined using a random-effects assumption, and predictors of rate of decline were evaluated using an autoregressive model. The rate of CD4% decline was approximately 1.2 CD4% lost per 6 months, with a higher rate in recent seroconverters (2.2 CD4% lost). The most important predictors of decline of the CD4% in autoregressive models were current pyogenic bacterial infection (CD4% reduced by 2.75, 95% confidence interval (Cl) 0.42-5.08), current report of a second constitutional symptom (CD4% reduced by 2.16, 95% Cl 0.03-4.29), and history of bacterial infection (CD4% reduced by 1.49, 95% Cl 0.09-2.89; proportion of prior CD4% lost increased by 0.14, 95% Cl 0.01-0.27). Oral thrush was not related to an accelerated rate of CD4% decline.

Original languageEnglish (US)
Pages (from-to)989-1000
Number of pages12
JournalAmerican Journal of Epidemiology
Volume137
Issue number9
StatePublished - May 1 1993

Fingerprint

Drug Users
Bacterial Infections
HIV
Lymphocytes
Oral Candidiasis
T-Lymphocytes
Injections
Methadone
Confidence Intervals

Keywords

  • Acquired immunodeficiency syndrome
  • HIV
  • T4 lymphocytes

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Epidemiology

Cite this

Correlates of the rate of decline of cd4+ lymphocytes among injection drug users infected with the human immunodeficiency virus. / Alcabes, Philip; Schoenbaum, Ellie; Klein, Robert S.

In: American Journal of Epidemiology, Vol. 137, No. 9, 01.05.1993, p. 989-1000.

Research output: Contribution to journalArticle

@article{1e7318d0ac7f48f28cd054a8e2cfd6a0,
title = "Correlates of the rate of decline of cd4+ lymphocytes among injection drug users infected with the human immunodeficiency virus",
abstract = "Changes in the level of CD4-bearing T-lymphocytes in injection drug users infected with the human immunodeficiency virus were evaluated in a sample of 318 subjects enrolled from a methadone program in the Bronx, New York, from 1985 through 1989. Follow-up continued through 1990. The percentage of CD4+ T-lymphocytes (CD4{\%}) was used to maximize the stability of measurements. The rate of decline of the CD4{\%} was determined using a random-effects assumption, and predictors of rate of decline were evaluated using an autoregressive model. The rate of CD4{\%} decline was approximately 1.2 CD4{\%} lost per 6 months, with a higher rate in recent seroconverters (2.2 CD4{\%} lost). The most important predictors of decline of the CD4{\%} in autoregressive models were current pyogenic bacterial infection (CD4{\%} reduced by 2.75, 95{\%} confidence interval (Cl) 0.42-5.08), current report of a second constitutional symptom (CD4{\%} reduced by 2.16, 95{\%} Cl 0.03-4.29), and history of bacterial infection (CD4{\%} reduced by 1.49, 95{\%} Cl 0.09-2.89; proportion of prior CD4{\%} lost increased by 0.14, 95{\%} Cl 0.01-0.27). Oral thrush was not related to an accelerated rate of CD4{\%} decline.",
keywords = "Acquired immunodeficiency syndrome, HIV, T4 lymphocytes",
author = "Philip Alcabes and Ellie Schoenbaum and Klein, {Robert S.}",
year = "1993",
month = "5",
day = "1",
language = "English (US)",
volume = "137",
pages = "989--1000",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Correlates of the rate of decline of cd4+ lymphocytes among injection drug users infected with the human immunodeficiency virus

AU - Alcabes, Philip

AU - Schoenbaum, Ellie

AU - Klein, Robert S.

PY - 1993/5/1

Y1 - 1993/5/1

N2 - Changes in the level of CD4-bearing T-lymphocytes in injection drug users infected with the human immunodeficiency virus were evaluated in a sample of 318 subjects enrolled from a methadone program in the Bronx, New York, from 1985 through 1989. Follow-up continued through 1990. The percentage of CD4+ T-lymphocytes (CD4%) was used to maximize the stability of measurements. The rate of decline of the CD4% was determined using a random-effects assumption, and predictors of rate of decline were evaluated using an autoregressive model. The rate of CD4% decline was approximately 1.2 CD4% lost per 6 months, with a higher rate in recent seroconverters (2.2 CD4% lost). The most important predictors of decline of the CD4% in autoregressive models were current pyogenic bacterial infection (CD4% reduced by 2.75, 95% confidence interval (Cl) 0.42-5.08), current report of a second constitutional symptom (CD4% reduced by 2.16, 95% Cl 0.03-4.29), and history of bacterial infection (CD4% reduced by 1.49, 95% Cl 0.09-2.89; proportion of prior CD4% lost increased by 0.14, 95% Cl 0.01-0.27). Oral thrush was not related to an accelerated rate of CD4% decline.

AB - Changes in the level of CD4-bearing T-lymphocytes in injection drug users infected with the human immunodeficiency virus were evaluated in a sample of 318 subjects enrolled from a methadone program in the Bronx, New York, from 1985 through 1989. Follow-up continued through 1990. The percentage of CD4+ T-lymphocytes (CD4%) was used to maximize the stability of measurements. The rate of decline of the CD4% was determined using a random-effects assumption, and predictors of rate of decline were evaluated using an autoregressive model. The rate of CD4% decline was approximately 1.2 CD4% lost per 6 months, with a higher rate in recent seroconverters (2.2 CD4% lost). The most important predictors of decline of the CD4% in autoregressive models were current pyogenic bacterial infection (CD4% reduced by 2.75, 95% confidence interval (Cl) 0.42-5.08), current report of a second constitutional symptom (CD4% reduced by 2.16, 95% Cl 0.03-4.29), and history of bacterial infection (CD4% reduced by 1.49, 95% Cl 0.09-2.89; proportion of prior CD4% lost increased by 0.14, 95% Cl 0.01-0.27). Oral thrush was not related to an accelerated rate of CD4% decline.

KW - Acquired immunodeficiency syndrome

KW - HIV

KW - T4 lymphocytes

UR - http://www.scopus.com/inward/record.url?scp=0027180609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027180609&partnerID=8YFLogxK

M3 - Article

C2 - 8100395

AN - SCOPUS:0027180609

VL - 137

SP - 989

EP - 1000

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 9

ER -